‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial
Successful results from trial of first-in-class Parkinson’s disease peptide
Researchers uncover how neurons deliver RNA where it is needed
Revvity to acquire Human Cell Design
Awakening dormant immune cells inside tumours to attack cancer​
CRISPR screen reveals genes required for brain development and a new neurodevelopmental disorder
Osaka looks to become global life sciences hub
Positive data moving breast cancer trial forward
Engineering dendritic cells boosts cancer immunotherapy
Ambros Therapeutics launches with $125m to take on complex regional pain syndrome type 1
ADEL and Sanofi sign $1.04bn licence agreement for Alzheimer’s therapy
Aukera Therapeutics emerges from stealth